CollaborationAntiverse and GlobalBio Inc. extend collab...Antiverse Ltd and GlobalBio Inc. have extend their cancer antibody partnership to progress two PD-1 modulators to preclinial development more ➔
ADCSOTIO Biotech licenses ADCs from Lonza sub...Sotio hsd licenced Synaffix’ ADC platform for up to US$740m to develop up to three next generation bioconjugates. more ➔
World Health Summit opened in BerlinOn Sunday, the World Health Summit with more than 300 speakers officially kicked off in Berlin. The three day event focuses on climate change and health, pandemic prevention, and digital technologie … more ➔
financingSynerkine Pharma BV secures EUR 12.1m in S...Dutch Synerkine Pharma BV has closed a Seris A extension financincg at €12.1m to accelerate clinical development of its pain killer SK-01. more ➔
imagingAI helps classifying brain tumours during...A method to quickly classify central nervous system (CNS) tumours, combining rapid sequencing and deep-learned AI models, may enable molecular diagnosis in less than 90 minutes, Dutch researchers re … more ➔
antibodyAgomab Therapeutics NV raises US$100m in S... Belgian fibrosis specialist Agomab Therapeutics NV has raised US$100m to advance development of its pipeline. more ➔
financingAstronauTx closes £48m Series A financingAlzheimer’s specialist AstronauTx Ltd has closed a £48m Series A financing to create new treatments for Alzheimer’s diseas more ➔
Bioindustra ConsortiumFrench team BioAroma awarded with BISC-E 2...At the celebration of the 10th anniversary of the Bio-based Industry Consortium (BIC), the student team BioAroma was presented with the BISC-E 2023 award, which comes with €5000 in prize money. more ➔
Orphan diseasesBreakthrough in microtia treatmentResearchers developed an innovative ear transplant method to treat microtia using tissue-engineered human skin and bioprinted cartilage. more ➔
cell modelsOrakl Oncology SA raises €3m to advance...Paris-based Orakl Oncology SA has raised €3m to develop its techbio platform for precision oncology. more ➔
